Residential College | false |
Status | 已發表Published |
Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials | |
Zhu, Xiao-Min1; Zheng, Wei2; Li, Xiao-Hong3; Cai, Dong-Bin4; Yang, Xin-Hu2; Ungvari, Gabor S.5; Ng, Chee H.6; Wang, Xiao-Ping7; Kulkarni, Jayashri8; Grigg, Jasmin8; Ning, Yu-Ping9; Xiang, Yu-Tao10 | |
2018-07 | |
Source Publication | SCHIZOPHRENIA RESEARCH |
ISSN | 0920-9964 |
Volume | 197Pages:288-293 |
Abstract | Objective: Raloxifene, a selective estrogen receptor modulator, has been used in treating postmenopausal women with schizophrenia with inconsistent results. This meta-analysis of randomized, double-blind, placebo-controlled trials (RCTs) examined its efficacy and safety for postmenopausal women with schizophrenia. |
Keyword | Raloxifene Postmenopause Women Schizophrenia Meta-analysis |
DOI | 10.1016/j.schres.2018.01.017 |
URL | View the original |
Indexed By | SCIE ; SSCI |
Language | 英語English |
WOS Research Area | Psychiatry |
WOS Subject | Psychiatry |
WOS ID | WOS:000437786100043 |
Publisher | ELSEVIER SCIENCE BV |
The Source to Article | WOS |
Scopus ID | 2-s2.0-85040771095 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Faculty of Health Sciences |
Corresponding Author | Ning, Yu-Ping; Xiang, Yu-Tao |
Affiliation | 1.Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China. 2.The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China 3.The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China. 4.Clinics of Chinese Medicine, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China 5.The University of Notre Dame Australia/Graylands Hospital, Perth, Australia. 6.Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia 7.Mental Health Institute of the Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry & Key Laboratory of Psychiatry, Mental Health of Hunan Province, Central South University, China 8.Monash Alfred Psychiatry Research Centre, Alfred Hospital, Melbourne, Australia; Monash University Central Clinical School, Monash University, Melbourne, Australia 9.The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. 10.Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macao SAR, China |
Corresponding Author Affilication | Faculty of Health Sciences |
Recommended Citation GB/T 7714 | Zhu, Xiao-Min,Zheng, Wei,Li, Xiao-Hong,et al. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials[J]. SCHIZOPHRENIA RESEARCH, 2018, 197, 288-293. |
APA | Zhu, Xiao-Min., Zheng, Wei., Li, Xiao-Hong., Cai, Dong-Bin., Yang, Xin-Hu., Ungvari, Gabor S.., Ng, Chee H.., Wang, Xiao-Ping., Kulkarni, Jayashri., Grigg, Jasmin., Ning, Yu-Ping., & Xiang, Yu-Tao (2018). Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. SCHIZOPHRENIA RESEARCH, 197, 288-293. |
MLA | Zhu, Xiao-Min,et al."Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials".SCHIZOPHRENIA RESEARCH 197(2018):288-293. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment